A highly sensitive, multiplex broad-spectrum PCR-DNA-enzyme immunoassay and reverse hybridization assay for rapid detection and identification of Chlamydia trachomatis serovars.
暂无分享,去创建一个
E. Weiderpass | W. Quint | L. van Doorn | W. Melchers | S. Morré | B. Kleter | K. Quint | M. D. de Koning | H. V. D. van den Munckhof | B. T. ter Harmsel | Gonneke Harbers
[1] P. Nilsson,et al. A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. , 2007, Sexually transmitted diseases.
[2] Xavier Castellsagué,et al. Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.
[3] F. Kong,et al. Use of PCR and Reverse Line Blot Hybridization Assay for Rapid Simultaneous Detection and Serovar Identification of Chlamydia trachomatis , 2006, Journal of Clinical Microbiology.
[4] T. Darville. Chlamydia trachomatis infections in neonates and young children. , 2005, Seminars in pediatric infectious diseases.
[5] J. Dillner,et al. Chlamydia trachomatis infection and persistence of human papillomavirus , 2005, International journal of cancer.
[6] R. Peeling,et al. Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study , 2004, International journal of cancer.
[7] S. Morré,et al. Combination of PCR Targeting the VD2 of omp1 and Reverse Line Blot Analysis for Typing of Urogenital Chlamydia trachomatis Serovars in Cervical Scrape Specimens , 2004, Journal of Clinical Microbiology.
[8] Robert E. Johnson,et al. Population-Based Genetic and Evolutionary Analysis of Chlamydia trachomatis Urogenital Strain Variation in the United States , 2004, Journal of bacteriology.
[9] N. Muñoz,et al. Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia. , 2003, Sexually transmitted infections.
[10] D. Mabey,et al. Lymphogranuloma venereum , 2002, Sexually transmitted infections.
[11] C. Black,et al. Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1) , 2001, Sexually transmitted infections.
[12] J. Albert,et al. Characterization of Chlamydia trachomatis omp1 Genotypes among Sexually Transmitted Disease Patients in Sweden , 2001, Journal of Clinical Microbiology.
[13] Wim Quint,et al. Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus , 1999, Journal of Clinical Microbiology.
[14] S. Morré,et al. Genomic Relatedness of ChlamydiaIsolates Determined by Amplified Fragment Length Polymorphism Analysis , 1999, Journal of bacteriology.
[15] J. Schachter,et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. , 1999, Bulletin of the World Health Organization.
[16] W. Quint,et al. Technical Advance Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses , 1998 .
[17] B. Van Der Pol,et al. Identification of a Chlamydia trachomatis Serovar E Urogenital Isolate Which Lacks the Cryptic Plasmid , 1998, Infection and Immunity.
[18] P. Piot,et al. Global prevalence and incidence estimates of selected curable STDs. , 1998, Sexually transmitted infections.
[19] J. Walboomers,et al. Serotyping and Genotyping of GenitalChlamydia trachomatis Isolates Reveal Variants of Serovars Ba, G, and J as Confirmed by omp1 Nucleotide Sequence Analysis , 1998, Journal of Clinical Microbiology.
[20] B. Munoz,et al. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. , 1997, The Journal of infectious diseases.
[21] M. Comanducci,et al. Characterization of a new isolate of Chlamydia trachomatis which lacks the common plasmid and has properties of biovar trachoma , 1997, Infection and immunity.
[22] W. M. Mac Kenzie,et al. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. , 1997, American journal of obstetrics and gynecology.
[23] A. de Vries,et al. Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars , 1994, Journal of clinical microbiology.
[24] R. Brunham,et al. Chlamydia trachomatis from individuals in a sexually transmitted disease core group exhibit frequent sequence variation in the major outer membrane protein (omp1) gene. , 1994, The Journal of clinical investigation.
[25] J. Sellors,et al. Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids , 1993, Journal of clinical microbiology.
[26] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[27] J. Ito,et al. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection , 1990, Infection and immunity.
[28] E. Peterson,et al. The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. , 1990, Plasmid.
[29] J. Ito,et al. Variation inVirulence among Oculogenital Serovars ofChlamydia trachomatis inExperimental Genital TractInfection , 1990 .
[30] K. Holmes,et al. Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington , 1983, Infection and immunity.